Introduction 30
Viruses and other mobile genetic elements (MGEs) are potential threats to most 31 studied cellular organisms, by acting as predators or by reducing fitness. In response, 32 organisms have evolved multiple defense strategies, largely grouped into innate and 33 adaptive systems. Innate systems are characterized by being activated by certain 34 preset features of infection. Adaptive systems, on the other hand, can learn to 35 recognize previously unrecognized pathogens. For a long time the vertebrate adaptive 36
Our basic system for expressing Cascade, Cas3, and crRNA in S. cerevisiae was 85 different plasmids from the pRSGal series, where each produced one of the 86 components ( fig. 1A ), but we also designed several alternative systems ( fig. 1B-D) . 87 pCascade, expressing Cascade proteins, had three cassettes with different cas genes 88 under control of bidirectional Gal promoters. The cassettes were separated by S. 89 cerevisiae CYC1 terminator to prevent formation of antisense transcripts. 90
For production of targeting crRNA, pCRISPR was constructed by inserting a CRISPR 91 array containing four copies of the J3 spacer (4×J3) (13) under control of a Gal 92 promoter, with a CYC1 terminator preventing read-through. 93
For expression of the Cas3 nuclease we designed pCas3 by cloning E. coli cas3 under 94 a Gal promoter. An alternative version of the plasmid, pCas3::Cse1, carried a 95 naturally occurring cas3-cse1 fusion (8). Co-expression of this plasmid with pCascade 96 would result in incorporation of the Cas3-Cse1 fusion in a part of the Cascade 97 complexes. To test the effect of different crRNAs we combined a CRISPR with two 98 alternative spacers, J1 and J2, with Cas3 or Cas3-Cse1 fusion to generate 99 pCRISPR+Cas3 and pCRISPR+Cas3::Cse1, respectively. 100
Two different target plasmids were designed. pTargetHigh carried a phage Lambda J 101 gene fragment containing the PAMs and protospacers for J1, J2, and J3 (table S4) on 102 a high copy vector. pTargetLow, carried the same J fragment on a low copy 103 backbone. Empty vectors lacking the J fragment were used as non-targeted controls. 104
105

Processing of crRNA in S. cerevisiae 106
To test function of crRNA processing in yeast we analyzed the formation of crRNA in 107 S. cerevisiae W303 after expression from pCascade, pCas3, and pCRISPR was 108 induced by addition of galactose. The analysis was performed by northern blot with a6 radioactively labeled probe complementary to the J3 spacer. The assay demonstrates 110 formation of a 61 nt RNA species, equal in size to crRNA produced in Escherichia 111 coli. The amount of crRNA produced was assayed two, four, and five hours after 112 induction, and crRNA was detected at all time points ( fig. 2A) We demonstrate successful reconstitution of bacterial type I-E CRISPR-Cas 146 interference in the eukaryote S. cerevisiae. We detect accurate processing of crRNA 147 by northern blot and, importantly, a reduction of target plasmid transformation rate 148 compared to a non-targeted control plasmid. We could not detect sequence 149 heterogeneity in plasmids recovered from transformed cells, demonstrating that the 150 level of interference observed was due to the activity of Cascade-Cas3 and not by 151 varying levels of escape mutations in the target. The lack of sequence heterogeneity 152 also demonstrates that NHEJ repair could not be detected, though this type of repair is 153 rare in S. cerevisiae. Our results suggest that the programmable processive DNA 154 degradation by type I-E CRISPR-Cas system can be restored in eukaryotic cells. 155
156
In our initial design, Cascade, Cas3, and pre-crRNA is expressed from different 157 plasmids, and this resulted in 50% reduction in plasmid transformation rate. To 158 improve activity we developed improved systems. Co-expression of a Cas3-Cse18 fusion results in a subpopulation of Cascade complexes permanently co-localized with 160
Cas3, which reduced transformation by 73.5 %, a level similar to when J3 crRNA is 161 used against phage Lambda in E. coli expressing the LeuO activator (13). We 162 hypothesize that this fusion improves the kinetics of target degradation, as the factors 163 do not need to find each other. Further, we altered the CRISPR to produce two 164 different crRNA targeting the plasmid to potentially increase activity and at the same 165 time expressed Cas3 and pre-crRNA from the same plasmid to reduce the load of 166 carrying multiple plasmids. These modifications resulted in further reduction of 167 transformation, and combination of all improvements result in about one-in-ten 168 plasmids escaping degradation. The large type I-E system is more difficult to establish heterologously than the more 182 compact class 2 systems. However, complete target clearance by type I systems is a 183 distinct advantage over inactivation of MGEs by mutagenesis using class 2 systems.
9
To inactivate an MGE by mutation, thorough understanding of the MGEs function is 185 required to find a key component to target. Also, compared to Cas9-based systems, 186 type I systems can easily target several different sequences by adding more spacer-187 repeat units to the CRISPR (14, 16), while current applications of Cas9 in eukaryotes 188 require insertion of multiple single guide RNA genes to achieve multiplexing (17). 189
Another benefit of our establishment of a type I-E system in S. cerevisiae is that it 190 functions as a platform for testing our current understanding of the system in a non- 
Materials and Methods 200
Strains and culture media 201
All cloning work was done in E. coli strain Top10. E. coli was cultured in Lysogeny 202
Broth (LB) with aeration at 37°C. When necessary, the media was supplemented with 203 kanamycin (50 μg/ml), ampicillin (100 μg/ml), streptomycin (50 μg/ml), tetracycline 204 (25 μg/ml), and chloramphenicol (15 μg/ml). For experiments in yeast Saccharomyces 205 cerevisiae W303 and BY418 strains were used. S. cerevisiae BY418 have full 206 deletion of chromosomal copies of genes used for selection, unlike W303 where they 207 are inactivated by point mutations. Yeast cells were cultured in SC medium (Yeast 208 nitrogen base 0.34 %, ammonium sulfate 0.5%, raffinose 2%, quadruple SC dropout 209 mix (CSM, -His, -Leu, -Trp, -Ura; Formedium™, UK) at the rate of 1400 mg/L of 210 medium, pH 5.6 ). For certain induction experiments SC medium with 1% raffinose 211 was used. When necessary, the media was supplemented with adenine sulfate (80 212 μg/ml), uracil (20 μg/ml), tryptophan (40 μg/ml), histidine (20 μg/ml), and leucine (60 213 μg/ml). 1.5% agar was included in the medium to prepare solid medium. Yeast strains 214
were grown with aeration at 30°C. 2% galactose was added to the medium for 215 induction of Gal promoter as required. For a complete list of strains used see table S1
. 216 217
Construction of vector expressing Cascade complex 218
A Gal1-10 promoter cassette from pRS425Gal was cloned between EcoRI/BamHI 219 sites of pBlueScript II SK (+) resulting in pUDM101. All cas genes were amplified by 220 colony PCR from E. coli MG1655, see table S2 for a complete list of primers. The 221 cse1 and cse2 genes were serially cloned into the pUDM101 XbaI and EcoRI sites, 222 respectively, to generate pUDM107. Similarly, cas7 and cas6e were serially cloned in 223 pRS425Gal BamHI and SalI sites, respectively, to generate pUDM108. The four 224 genes were combined by subcloning a HindIII-NotI blunt fragment from pUDM107 225 into the blunted SacI site of pUDM108, thereby generating pUDM109. The cas5e 226 gene was cloned into pRS425Gal vector to generate pUDM110. CYC1 terminator 227 cassette was PCR amplified from pYES2 and subcloned into PstI site of pBlueScript 228 II SK (+) to generate pUDM102. A CYC1-cas5e-CYC1 cassette was constructed by 229 serially cloning EcoRV-SmaI fragment from pUDM102 into the SalI and SpeI sites 230 respectively of pUDM110 to generate pUDM315. Using XhoI and NotI this cassette 231 was excised from pUDM315, blunted and sub-cloned into the NotI site of pUDM109 232 to generate the final Cascade-expressing construct, pCascade. See table S3 for 233 complete list of plasmids used in this study.
235
Construction of vectors expressing Cas3 or Cas3-Cse1 fusion 236
The cas3 gene was PCR amplified from MG1655 to introduce flanking EcoRI sites 237 and cloned into the EcoRI site of pRS423Gal resulting in the Cas3-expressing plasmid 238 pCas3. A Cas3-Cse1 fusion fragment was amplified from pWUR657 and cloned 239 between the SpeI and NotI sites of pRS423Gal to generate pCas3::Cse1 expressing 240 the Cas3-Cse1 fusion. S. cerevisiae W303 carrying pCascade, pCRISPR (4xJ3 spacer), and pCas3 was 277 grown to stationary phase, diluted in fresh SC medium and grown with aeration at 278 32°C to an OD600 value of 0.3. Galactose was then added to induce the CRISPR-Cas 279 system. 10 ml culture was harvested by centrifugation 2, 4, and 5 hours after 280 induction. Total RNA was isolation using the hot phenol method (21). 281
Sample preparation and RNA purification: Bacteria 282
Overnight culture of E. coli BL21AI harboring pWUR397 (Cas3), pWUR400 283 (Cascade) and pLA002 (minimal J3 CRISPR array), was diluted and grown to OD600 284 ≈ 0.3. Cas-protein and crRNA expression was induced by addition of 0.2 % arabinose 285 and 1 mM IPTG. After 30 min, 5 ml sample was taken and mixed with 1 ml stop 286 solution (5 % phenol, 95 % ethanol), and pelleted at 4 °C. RNA was purified as 287 previously described (22) . 288
Gel and blotting 289
Samples were run on a 10% denaturing polyacrylamide gel (10 % polyacrylamide, 7 290 M urea, 1X Tris-borate-EDTA (TBE)) in 1X TBE. Samples were mixed with loading 291 dye (95 % deionized formamide, 0.5 mM EDTA, 0.025 % bromphenol blue/xylene 292 cyanol, and 0.025 % SDS), and boiled 3 min prior to loading. The same was done 293 with the pre-labelled pUC8 size marker. 15 µg of total RNA was loaded for each 294 sample. As a positive control for processed crRNA, total RNA purified from the E. 295 coli BL21AI carrying pWUR 397, pWUR400 and pLA002, able to prevent phage 296 infection and plasmid transformation (data not shown), was also loaded on the gel. 297
Transfer to Hybond N+ membrane (Amersham) was done at 4°C overnight at 200 298 mA. The membrane was UV crosslinked and prehydridized in Church buffer (0.25M 299 sodium phosphate buffer pH 7.2, 1 mM EDTA, and 7% SDS) for 1 h at 42°C after 300 which 0.5 µM of radioactively labelled probe was added to the buffer. Hybridization 301 was done overnight. The membrane was washed two times 5 min with 2x SSC, 0.1% 302 SDS and exposed the PharosFX-system (BioRad). 303
The pUC8 size marker (Fermentas) was radioactively labeled using γ-32 P-ATP 304 (PerkinElmer) and PNK (Fermentas) in an exchange reaction according to the 305 manufacturer's instructions. The probe, LA014, was labelled the same way in a 306 forward reaction. Excess γ-32 P-ATP was removed using Illustra ProbeQuant G-50 307 RNA from an E. coli strain active for interference was used as positive control. B-E: 435
